Argatroban, a new treatment option for heparin-induced thrombocytopenia.
Cleveland
Kevin W
KW
Idaho Drug Information Service, Idaho State University College of Pharmacy, Pocatello, Idaho, USA.
D000925:Anticoagulants / Q000009:adverse effects*; D000991:Antithrombins / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D001120:Arginine / Q000031:analogs & derivatives; D001777:Blood Coagulation / Q000187:drug effects; D001780:Blood Coagulation Tests; D002809:Chondroitin Sulfates / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use; D003422:Critical Care / Q000379:methods; D003871:Dermatan Sulfate / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use; D004338:Drug Combinations; D016527:Drug Costs; D016903:Drug Monitoring / Q000379:methods; D006493:Heparin / Q000009:adverse effects*; D006497:Heparan Sulfate / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use; D006629:Hirudins / Q000031:analogs & derivatives* / Q000191:economics / Q000494:pharmacology; D006801:Humans; D010875:Pipecolic Acids / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use; D013449:Sulfonamides; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000145:classification / Q000188:drug therapy*
D000925:Anticoagulants; D000991:Antithrombins; D001120:Arginine; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D004338:Drug Combinations; D006493:Heparin; D006497:Heparan Sulfate; D006629:Hirudins; D010875:Pipecolic Acids; D011994:Recombinant Proteins; D013449:Sulfonamides; C035838:danaparoid; C031942:argatroban; C083544:lepirudin